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Abstract: Bovine babesiosis is an acute and persistent tick-borne global disease caused mainly by the
intraerythrocytic apicomplexan parasites Babesia bovis and B. bigemina. B. bovis infected erythrocytes
sequester in blood capillaries of the host (cytoadhesion), causing malaria-like neurological signs.
Cytoadhesion and antigenic variation in B. bovis are linked to the expression of members of the
Variant Erythrocyte Surface Antigen (VESA) gene family. Animals that survive acute B. bovis infection
and those vaccinated with attenuated strains remain persistently infected, suggesting that B. bovis
parasites use immune escape mechanisms. However, attenuated B. bovis parasites do not cause
neurological signs in vaccinated animals, indicating that virulence or attenuation factors play roles in
modulating parasite virulence phenotypes. Artificial overexpression of the SBP2t11 protein, a defined
attenuation factor, was associated with reduced cytoadhesion, suggesting a role for this protein as a
key modulator of virulence in the parasite. Hereby, we propose a model that might be functional
in the modulation of B. bovis virulence and persistence that relies on the interplay among SBP2t,
VESA proteins, cytoadhesion, and the immune responses of the host. Elucidation of mechanisms used
by the parasite to establish persistent infection will likely contribute to the design of new methods for
the control of bovine babesiosis.
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1. Introduction
Apicomplexa is a phylum of obligatory parasitic protozoans that are comprised of the obligate
endoparasites of animals and humans, which share complex apical structures in their zoite stages and
are specialized for cell attachment and invasion [1]. Apicomplexans are among the most successful
parasitic organisms existing in nature due to their ability to invade and survive inside different hosts [2].
Although the structure of the apical complex varies slightly among apicomplexans, typically it includes
secretory organelles known as micronemes, rhoptries, and dense granules or spherical bodies (Figure 1).
Other structures associated with the apical complex are the conoid (only present in coccidian) and polar
rings [1]. Additionally, apicomplexan parasites have a non-photosynthetic plastid structure (apicoplast),
which probably originated from a red alga by a process of endosymbiosis [3]. The complement of
secretory organelles contains proteins needed for cell invasion, a critical parasite function that usually
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causes pathological consequences for the host, and thus at least some apical complex molecules could
be considered as virulence factors. Babesia are tick-borne apicomplexan parasites that are the causative
agents of babesiosis: one of the most common arthropod-borne infections of free-living animals
worldwide [4]. More than 100 species of Babesia can infect numerous tick vectors and mammalian
hosts, and among them, Babesia bovis and B. bigemina (the causative agents of bovine babesiosis) have a
large impact on the beef and dairy industries in many tropical and semi-tropical regions worldwide.
The incidence of bovine babesiosis is increasing due to the lack of available effective vaccines together
with an expansion of the geographical range of its tick (Riphicephalus spp.) transmission vector (mainly
R. microplus), largely driven by climatic change and other human interventions. Other important
risk factors include increased presence of acaricide-resistant tick vectors, and, in the case of the USA,
the increase in cattle importation from endemic countries [5]. An additional source of concern is the risk
of transmission resulting from free-moving wild animals that are infested with Babesia-infected ticks [6].
Since babesiosis is geographically restricted to tropical and subtropical areas due to environmental
requirements by their tick vectors, climate change results in the expansion of the geographical niche of
the tick vectors able to transmit the disease into regions that were previously considered as non-endemic
in recent years [7]. Overall, babesiosis has a large and significant economic impact on the beef and
dairy industries due to mortality, ill-thrift, abortions, loss of milk and meat production, treatment cost,
and ultimately, impact on international cattle trade [6].
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Figure 1. General Apicomplexa structure. Apicomplexan parasites, in addition to nucleus, ribosomes, 
endoplasmic reticulum, mitochondria, and Golgi complex, have a characteristic apical complex that 
includes the secretory organelles known as micronemes, rhoptries, dense granules or spherical 
bodies, conoid, and polar rings. Apicomplexan parasites have an apicoplast (Cryptosporidium does not 
have apicoplast). Cryptosporidium have mitochondria reduced in size and function known as a 
mitosome. 
2. Babesia Life Cycle 
The life cycle of Babesia spp. consists of merogony, gametogony, and sporogony (Figure 2). 
Babesia is naturally transmitted transovarially by the bite of infected Ixodid tick larva and nymphs for 
B. bovis and B. bigemina, respectively. Motile sporozoites stored within the salivary glands of the ticks 
are injected into the mammalian host, where they infect erythrocytes [8]. Once inside the erythrocyte, 
sporozoites develop into trophozoites where binary fission occurs forming merozoites. Merozoites 
egress from infected erythrocytes and re-infect other erythrocytes. Some trophozoites undergo 
gametogenesis in the midgut of the tick and develop into Strahlenkörper forms. These fuse to form 
zygotes, which then develop into motile kinetes. Through the hemolymph of the tick, motile kinetes 
invade different tick organs, including the ovary, where they can access tick eggs, thus leading to 
transovarial transmission. Finally, the parasites reach the salivary glands of the larva of the next 
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2. Babesia Life Cycle
The life cycle of Babesia spp. consists of merogony, gametogony, and sporogony (Figure 2). Babesia
is naturally transmitted transovarially by the bite of infected Ixodid tick larva and nymphs forB. bovis and
B. bigemina, respectively. Motile sporozoites stored within the salivary glands of the ticks are injected
into the mammalian host, where they infect erythrocytes [8]. Once inside the erythrocyte, sporozoites
develop into trophozoites where binary fission occurs forming merozoites. Merozoites egress from
infected erythrocytes and re-infect other erythrocytes. Some trophozoites undergo gametogenesis in
the midgut of the tick and develop into Strahlenkörper forms. These fuse to form zygotes, which then
develop into motile kinetes. Through the hemolymph of the tick, motile kinetes invade different tick
organs, including the ovary, where they can access tick eggs, thus leading to transovarial transmission.
Finally, the parasites reach the salivary glands of the larva of the next generation of ticks, where the
parasites form multi-nucleated sporoblasts. Resulting sporozoites are then injected into the mammalian
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host as the ticks acquire a blood meal [9]. Inoculation of Babesia sporozoites by larva (B. bovis) or nymph
(B. bigemina) stages of the vector Riphicephalus ticks into naïve animals may result in acute babesiosis.
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3. Acute and Persistent Babesia Infections
Acute symptoms of babesiosis are broad, ranging from a sub-clinical infection to a fulminant
malaria-like disease, which can be fatal [4]. The severity of the disease depends on the age of the
mammalian host, the competency of the host immune system, and co-infection with other pathogens [4].
The only method available to prevent acute bovine babesiosis, at least to some degree, is the use of
live-attenuated vaccines. Such vaccines comprise attenuated parasite strains that are derived from
virulent strains that have undergone a series of rapid passages in calves [10–12]. The B. bovis attenuated
vaccine strains are generated by rapid serial passages (usually 22 to 28) of blood containing infected
erythrocytes in splenectomized calves [11,13], while B. bigemina vaccine strains are generated by serial
passages of infected erythrocytes in spleen intact calves [14]. Again, the attenuated parasites cause mild
disease in vaccinated animals, but these parasites also can transit into persistent disease, on the face of
the immune response of the hosts. The mechanisms involved in the attenuation of Babesia parasites by
passage in calves remain unknown. However, among other possibilities, attenuation may be due to the
selection of a preexisting attenuated subpopulation in the virulent strain by the successive passages,
or due to the occurrence of genetic or epigenetic changes in the parasites resulting in changes of their
virulence phenotype. Regardless of the mechanisms involved, comparisons of virulent/attenuated,
genetically-related pairs of parasites using genomic and transcriptomic approaches allowed the
discovery of genes that are differentially expressed in attenuated parasites, as described below.
Although highly genetically related, B. bovis and B. bigemina cause distinct pathologies in infected
cattle. While both parasites are responsible for increased fever and anemia, and for other signs
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related to massive destruction of erythrocytes, B. bigemina causes milder acute disease followed by
persistent disease in surviving animals. In contrast, virulent strains of B. bovis cause acute infections,
characterized by neurological signs such as ataxia, lethargy, and inappetence [15]. Neurovirulence is
most likely related to the cytoadhesion of infected erythrocytes to vascular endothelial cells and
their subsequent sequestration in the cerebral microvasculature [16,17], resulting in altered blood
flow and inflammation [18]. Neither sequestration nor neurological signs occur in animals infected
with B. bigemina. However, the receptors involved in the interactions between B. bovis infected
erythrocytes and host endothelial cells remain unknown. It is possible that changes in the surface
architecture of the infected erythrocytes, such as ridges mediated by the parasites, facilitate this
process. In addition, parasite proteins expressed on the surface of the infected erythrocyte, such as the
members of the Variant Erythrocyte Surface Antigen (VESA) family, have been identified as possible
candidates for mediating such interactions, but it is possible that other still uncharacterized molecules
participate directly or indirectly in this mechanism. Less is known about molecules expressed on
the endothelial cells lining the vasculature that can bind to receptors expressed on the surface of
infected erythrocytes. Animals infected with virulent strains of Babesia parasites also suffer from
hyperthermia (≥39 ◦C) for three or more days, with decreases in hematocrit greater than 40%. These,
combined severe clinical signs, usually require chemotherapeutic intervention to prevent the fast demise
of infected animals. In contrast, B. bovis attenuated strains derived artificially from the virulent parental
strains do not induce neurovirulence in inoculated young calves, which are usually more resistant
to infection [17,18]. Additionally, hosts infected with attenuated strains display reduced erythrocyte
sequestration, less hyperthermia, and a lower decrease in hematocrit [17,18]. These vaccinated animals
survive with no chemotherapeutic intervention, and thus live vaccines based on attenuated B. bovis
strains are frequently used in endemic countries. Cytoadhesion of infected erythrocytes remains an
important mechanism that enables the development of persistent infection, which is subsequent to the
acute stage. A feature of persistent infection is low levels of fluctuating parasitemia, which results in the
occurrence of asymptomatic cattle in endemic areas that function as reservoirs that assure transmission
of the parasite.
Immunological studies have demonstrated that an important mechanism that protects cattle from
severe manifestations of the disease is the clearance of the parasites from the circulation mediated
by macrophages in the spleen [19–21]. However, there is consensus that the ability of B. bovis to
sequester in capillaries of the host (mainly in the brain and kidney, as well as in other organs) helps
the parasite to avoid the immune responses of the hosts, and particularly, the trapping of infected
erythrocytes mediated by macrophages residing in the spleen of the hosts. This ‘parasite escape’
strategy is similar to the mechanisms used by Plasmodium parasites to avoid clearance by the host
immune system [22,23]. Furthermore, and in a fashion similar to Plasmodium, sequestration of infected
erythrocytes in brain microvasculature is also responsible for the generation of the neurological
symptoms [17,24]. The mechanisms involved in sequestration of B. bovis remain poorly defined, but it
is known that B. bovis express proteins that can produce important modifications in the architecture of
the infected erythrocyte [25–29]. In addition to cytoadhesion and sequestration, the parasite is also able
to generate antigenic diversity in the molecules exposed on the erythrocyte surface, such the members
of the VESA family, to escape the antibody responses of the host [30,31]. In summary, cytoadhesion and
rapid antigenic variation acting together are widely considered as the main mechanisms used by
B. bovis to allow persistent infections.
4. Immune Mechanisms of Persistent Babesia Infections
The outcome of a B. bovis infection depends on the balance between host and parasite responses to
the inflammatory response induced by the parasite. After acute infection, animals either die or recover
from the infection either naturally or after drug treatment. After recovery, the parasite establishes
persistency and the host become chronically infected [19].
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Following a tick bite, at the site of infection, an innate immune response against infected
erythrocytes or free Babesia merozoites is initiated [8]. Different Babesia pathogen associated molecular
patterns (PAMPs) bind to mammalian toll-like receptors (TLRs) expressed on neutrophils or monocytes,
a process responsible for the initiation of the host innate immune response. Mainly, non-methylated
CpG motifs of DNA bind to bovine TLR9 [32,33]. Monocytes or phagocytic neutrophils release
cytokines such as IL-B, TNF-α, and Nitric Oxide (NO) in Babesia infections [34] and in chemokines that
attract immature dendritic cells (iDC). Also, Natural Killer cells (NK) have been identified in the early
stages of Babesia infection [35]. NKs release interleukin (IL) IL-12, IL-18, and IFNγ [21,36]. Mature DC
(mDC) migrate to secondary lymphoid tissue, such as the spleen or lymph nodes, at the beginning
of the acute infection, which is characterized by high parasitemia, fever, anemia, drop of hematocrit,
and organ failure. In the spleen, the mDC present Babesia antigens to naïve T cells. Spleen macrophages
activated by IFNγ [21,36] kill the parasite by phagocytosis and the activity of toxic metabolites such
as NO [34]. The important role of macrophage activation was demonstrated by in vitro experiments
where macrophages secreted products such as 1L-1β, 1L-12, and TNF-α, which inhibited in vitro
B. bovis growth [21] (Figure 3).
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Figure 3. Immune regulation of Babesia infection toward Persistence. During the bite, the ticks insert
their mouthparts into the skin on their host and cause tissue injury, creating hemorrhagic pools where
Babesia sporozoites stimulate host innate immune response. Babesia pathogens associated molecules
patterns (PAMPS) bind to the mammalian toll-like receptors (TLRs) on neu oph ls or monocytes.
Monocytes or phagocytic neutrophils release cytokines such as IL-B, T F-α, and Nitric Oxide (NO),
and chemokines attract immature dendritic cells (iDC). Natural Killer cells (NK) release in erl ukines
(IL) such as IL-12, IL-18, IFNα, and IFNγ. iDC release IL-12 and IL-15. Mature DC (mDC) migrate to
secondary lymphoid tissue such as the spleen or lymph nodes. In the spleen, the mDC present Babesia
antigens to naïve T cells. Spleen macrophages activated by IFNγ kill the parasite by phagocytosis,
and kill the activity of toxic metabolites such as NO and secreted products such as 1L-1β, 1L-12,
and TNF-α, which inhibit B. bovis growth. The mature DC present antigens to CD4+ T cells. CD4+ T
cells produce IFN-γ and IL-4. B cells produce IgG1 and opsonizing IgG2 antibodies. Control of acute
Babesia infection results in the development of chronic disease and persistence where adaptive immune
response is present. During persistent B. bovis infection, there are not evident clinical symptoms,
but the animals still have low fluctuating parasitemia because infected erythrocytes cytoadhered to the
host microvasculature.
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Acquired immunity after immunization with a B. bovis vaccine or recovery from infection
is based on CD4+ T cells, macrophages, and antibody production [20]. The mature DC present
antigens to CD4+ T cells. CD4+ T cells levels were high from animals protected against B. bovis
infection [37]. Activated spleen macrophages produce cytokines, such as IFN-α, IL-12, and IL-18,
that stimulate CD4+ T cells. CD4+ T cells produce IFN-γ and IL-4 [38]. IFN-γ is required for activating
macrophages to produce babesiacidal molecules and for enhancing an opsonizing IgG2 antibody
response. IL-4 produced by CD4+ enhances IgG1 production. Both antibody and activated CD4+ T cells
are important for maintaining protective immunity in B. bovis [20] (Figure 4). However, because Babesia
parasites reside inside erythrocytes, which do not express MHC molecules, mechanisms involving
direct effector activities of lymphocytes, such as cytotoxic lymphocytes, are not considered relevant for
effective control.
Pathogens 2019, 8, x FOR PEER REVIEW 2 of 13 
(IL) such as IL-12, IL-18, IFNα, and IFNγ. iDC release IL-12 and IL-15. Mature DC (mDC) migrate to 
secondary lymphoid tissue such as the spleen or lymph nodes. In the spleen, the mDC present Babesia 
antigens to naïve T cells. Spleen macrophages activated by IFNγ kill the parasite by phagocytosis, and
kill the activity of toxic metabolites such as NO and secreted products such as 1L-1β, 1L-12, and TNF-
α, which inhibit B. bovis growth. The mature DC present antigens to CD4+ T cells. CD4+ T cells 
produce IFN-γ and IL-4. B cells produce IgG1 and opsonizing IgG2 antibodies. Control of acute
Babesia infection results in the development of chronic disease and persistence where adaptive 
immune response is present. During persistent B. bovis infection, there are not evident clinical 
symptoms, but the animals still have low fluctuating parasitemia because infected erythrocytes 
cytoadhered to the host microvasculature. 
cquired i unity after i unization with a B. bovis vaccine or recovery from infection is
based on CD4+ T cells, macrophages, and antibody production [20]. The mature DC present antigens 
to CD4+ T cells. CD4+ T cells levels were high from animals protected against B. bovis infection [37].
Activated spleen macrophages produce cytokines, such as IFN-α, IL-12, and IL-18, that stimulate 
CD4+ T cells. 4+ T cells produce IFN-γ and IL-4 [38]. IFN-γ is required for activating macrophages 
to produce babesiacidal molecules and for enhancing an opsonizing IgG2 antibody response. IL-4
produced by CD4+ enhances IgG1 production. Both antibody and activated CD4+ T cells are 
important for maintaining protective im unity in B. bovis [20] (Figure 4). However, because Babesia
parasites reside inside erythrocytes, hich do not express  olecules, echanis s involving
direct effector activities of lymphocytes, such as cytotoxic lymphocytes, are not considered relevant 
for effective control. 
Figure 4. Proposed model of a possible mechanism of attenuation in Babesia bovis. SBP2 and SBP2 
truncated proteins (SBP2t7, SBP2t9, and SBP2t11) might be involved in protein-protein interactions,
in a mode that inhibits or regulates ridge formation in B. bovis infected erythrocytes. In the virulent B.
bovis infected-erythrocytes (right figure), sbp2 truncated transcripts are down-regulated, which could 
correlate to their protein levels; Variant Erythrocyte Surface Antigen (VESA) proteins forming the
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endothelial cells. These receptors could be EC receptors, I-CAM1, CD36, P-selectin, CSA, or CD31 as 
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Fig re 4. ro ose o el of a ossible echanis of atten ation in Babesia bovis. S 2 an S 2
tr cate r tei s ( 2t7, 2t9, a 2t11) i t e i l e i r tei - r tei i teracti s,
i t t i i its r re lates ridge formation in B. bovis infected erythrocytes. In the virulent
B. bovis infected-erythrocytes (right figure), sbp2 truncated transcripts are -r l t , i l
l t t t i t i l l ; aria t r t r c t rf ti ( r t i f i t
re expressed on the surface on infected erythrocytes, especially in the tips
of numerous ridges. Thus, the VESA h terodimer is interacting with undefined r t rs t
t elial cel s. ese receptors could be EC receptors, I-CAM1, CD36, P-sel ctin, CSA, or CD31 as it
occurs in Plasmodium. Thus, cytoadhesion in a virulent strain to endothelial c ll i
si e, in the attenuated B. bovi strain infected erythrocyte, sbp2 truncated transcripts
are up-regulated, which could correlate to their protein levels; VESA proteins are not forming the
heterodimer VESAαβ, and the number of ridges is reduced. Thus, the binding to VESA-receptors
is interrupted and cytoadhesion to endothelial cells is reduced. Additionally, undefined erythrocyte
cytoskeleton proteins (Spectrin, Band 3, Band 4.1, Ankyrin R, and Actin) could be interacting with SBP
proteins as well.
The outcome of the acute infection depends on the timing, production, and quantity of cytokine
response. Innate response is protective when IFNγ and IL-12 are produced before IL-10 production.
However, the innate response is not protective when IL-10, IL-12, and IFNγ are produced at the
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same time [39]. Control of acute Babesia infection results in the development of chronic disease and
persistence where adaptive immune response is present. During persistent B. bovis infections, there are
not evident clinical symptoms because the infection is controlled, but the animals still have low
fluctuating parasitemia. It is possible that parasite persistence, in the face of a strong immune response,
is aided by the cytoadhesion of infected erythrocytes to the host microvasculature, which allows the
parasite to avoid elimination by spleen macrophages. It has been suggested that it is beneficial for the
parasite to induce sufficient protective immunity that would prevent death of the host, facilitate parasite
persistence, and assure further transmission to a new host [19] (Figure 3). Thus, persistence results in a
balance where the parasite assures its transmission to the host and its survival. It is also possible that
the parasite puts into action mechanisms that facilitate persistence in an unfavorable environment
where it can co-exist with the strong defenses mediated by the immune system of the host, such as
antigenic variation and sequestration, and/or by modulating its virulence. In addition, Babesia parasites
can also use mechanisms of persistence based on the modulation or interference with the effector arms
of the immune system, as exemplified by the expression of immunoglobulin receptors on the surface
of infected erythrocytes by B. bigemina [40].
5. Interplay among Babesia and Its Hosts
Babesia parasites have co-evolved with their definitive arthropod tick vectors and the intermediate
vertebrate hosts developing mechanisms that lead to parasite perpetuation. These mechanisms involve
the production and interplay of virulence and attenuation factors. However, the interactions among
the parasite and the vertebrate host are also strongly influenced by the responses of the immune
system. The immune system of the bovine is known to generate a massive humoral immune response
against the detection of bovine babesiosis [41–43], upon controlling acute infections. The result of these
interactions is usually a balance that is mainly reached upon the establishment of persistent infections
where the parasite assures its transmission and host survival.
The restriction on the expansion of parasite numbers in persistently infected animals occurs
despite the expression of variable VESA antigens (see below) on the surface of the infected erythrocytes,
which is regarded as an escape strategy of the parasite. This observation suggests that effective control
of the number of circulating parasites could be due mainly to the destruction of free merozoites,
rather than infected erythrocytes. This is supported by the large amount of surface merozoites antigens
recognized by sera of persistently infected cattle, including antigens of the Variable Merozoite Surface
Antigen family (VMSA) [44] and the absence of clinical manifestations, such as splenomegaly and signs
of hemolytic anemia, in persistently infected animals. The VMSA is a family of antigens, that includes
MSA-1 and MSA2a, b, and c, that is not subjected to fast antigenic variation, but it is in contrast highly
variable among distinct strains of the parasite [45–47]. Overall, these observations suggest the existence
of a unique interplay between the parasite and the immune system of the host where both the host and
the parasites are benefited.
On the other hand, cytoadhesion thus prevents infected erythrocytes from circulating through the
spleen where they would be eliminated by phagocytosis. This mechanism seems to be operative during
both acute and persistent infections and is central to control the infection. Paradoxically, parasite survival
relies on the occurrence of an effective immune system, which can regulate uncontrolled development
of the parasite in the host for its survival at the population level, and thus expresses attenuation factors
that can modulate the virulence and move the tip in the direction of survival for both the host and
the parasite.
6. Possible Role of Attenuation Factors in Modulating Persistent Infection and Virulence
The mechanism underlying parasite attenuation through passage is not fully understood, but some
evidence of changes occurring at the genomic, transcriptomic, proteomic, and pathophysiological
levels has been collected so far. First, comparative genomic analysis of B. bovis virulent and attenuated
strain pairs suggested minimal changes at the coding level among the virulent and attenuated strain
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pairs, and attenuation may be a strain-specific acquired phenotype, although all attenuated derivatives
consist of significantly reduced genomic content [48].
Second, the subsequent transcriptome analysis of two virulent and attenuated strain pairs revealed
significant differential gene expression. Specifically, three spherical body protein (SBP) 2 gene family
members were found up-regulated in the Argentina and Texas attenuated strains: sbp2t7, sbp2t9,
and sbp2t11 [49]. Additionally, sbp2t11 was found consistently up-regulated in multiple attenuated
strains, when compared to their virulent counterparts [50]. This altered gene expression pattern,
exclusive to the attenuated strains, suggests that sbp2t11 may be a universal attenuation marker for
B. bovis [49,50].
Third, there is likely a connection between low cytoadhesion and attenuation [34]. As it was
mentioned previously, cytoadhesion in bovine babesiosis occurs as B. bovis infected erythrocytes adhere
to capillary endothelial cells in vivo, resulting in the concentration of infected erythrocytes in the host
microvasculature [16,51]. This parasite strategy has been proposed to result in the avoidance of parasite
splenic clearance while it facilitates establishing persistent infection [52]. The observation that significant
differences in the number of sequestered parasites in cerebral capillaries were detected between animals
infected with Texas virulent and attenuated strains [17] suggests that cytoadherence is a mechanism
that might be closely correlated with virulence. Consistent with this postulate, artificial up-regulation
of the attenuation marker sbp2t11 was also associated with low cytoadhesion [53].
Fourth, there remains an unexplored relationship between VESA and attenuation. The Variant
Erythrocyte Surface Antigen 1 (VESA) protein is the largest protein family in B. bovis and it has been
associated to cytoadherence and antigenic variation [29,54]. VESA protein is a heterodimer formed by a
1α and a 1β subunit [55]. Ves genes encode the VESA proteins; the VESA1α subunit is encoded by >150
Vesα genes and theβ subunit is encoded by >80 vesβ genes [56]. Vesα and vesβ are divergently oriented
and hypothesized to be transcribed at the locus of active transcription, resulting in the expression of
VESA1αβ heterodimer on the erythrocyte surface [54,55,57]. Previously, it was demonstrated that
antibodies generated during acute babesiosis infection disrupted infected erythrocytes and endothelial
cells bonds [58]. Also, a variable, polymorphic doublet VESA1 protein was immunoprecipitated from
this serum using Babesia hyperimmune IgG serum to precipitate L-35S methionine-labeled parasite
proteins [58]. In addition, VESA proteins were found to be associated with ridges that are present in the
surface of B. bovis infected erythrocytes. Such ridges are also likely to be responsible for facilitating the
cytoadherence of infected erythrocytes to vascular endothelial cells [58], and certain attenuated B. bovis
strains display reduced numbers of ridges [59,60]. Collectively, these data suggest the possibility
that cytoadherence is associated with the expression of VESA proteins [58]. In addition, since VESA
proteins are known for their high degree of variation and differential patterns of expression through
the infection, it has been suggested that they may also assist the parasite to escape the host immune
system. According to a transcriptome analysis [49], in virulent B. bovis strains, the variant erythrocyte
surface antigen (ves) αβ pair genes are up-regulated and divergently oriented meanwhile sbp genes are
down-regulated. On the other hand, in attenuated B. bovis strains, ves genes are up-regulated but the
heterodimers are unpaired, meanwhile sbp genes are up-regulated [49].
The actual molecular mechanisms explaining the relationships among sbp2t11 levels and
cytoadherence remain unknown. VESA proteins and/or other erythrocyte cytoskeleton proteins
could be interacting with Babesia proteins such as the SBP proteins in a similar panorama as previously
reported for Plasmodium [61–63]. P. falciparum erythrocyte membrane protein (PfEMP1) mediates
cytoadhesion in P. falciparum, undergoes antigenic variation, and is encoded by the var multigene family.
Thus, the PfEMP1 pattern of expression influences the severity of the malaria disease [64]. Both the
N-terminal and the C-terminal portion of PfEMP1 participate in important interactions: the extracellular
N-terminal portion of PfEMP1 interacts with different host receptors such as I-CAM1, CD36, P-selectin,
and chondroitin sulfate A (CSA); meanwhile, the intracellular C-terminal portion of PfEMP1 interacts
with the knob-associated histidine-rich protein (KAHRP), which has been implicated in the formation
of knobs on the surface of P. falciparum-infected erythrocytes [65]. KAHRP contains a 63-amino
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acid histidine-rich region, two variable repeat tandem regions, and several protein-binding domains
that facilitate the interaction with different parasite and host proteins involved in a cytoadhesion
complex [62,66]. Disruption of genes involved in PfEMP1 trafficking and the kahrp gene cause dramatic
reduction in the formation of knobs and cytoadherence, which may be equivalent to the ridges present on
the surface ofB. bovis infected erythrocytes [65,67]. Additionally, down-regulation of chaperone proteins
involved in PfEMP1 transport may affect var gene regulation in severe malaria [68]. Like KAHRP,
sbp2t11 has an N-terminal signal peptide and a PEXEL-like motif responsible for its maturation and
trafficking to spherical bodies. Some proteins staged within the spherical bodies, such as the Smorf
proteins, undergo release during or immediately following erythrocytes invasion. SBP2t11 may be
involved in staging of proteins, or may directly influence cytoadhesion. Data so far collected from
Babesia infected erythrocytes do not distinguish between these possibilities. No significant sequence
homology exists between Plasmodium and Babesia proteins known to be involved in cytoadhesion,
and it is likely that these proteins have evolved independently because of convergent evolution,
perhaps playing similar functional roles in these two distinct parasites.
7. Concluding Remarks: Proposed Model of a Possible Mechanism of Attenuation in Babesia bovis
Based on experimental data, it is reasonable to speculate that the B. bovis VESA and SBP2
proteins have similar characteristics and roles as PfEMP1 and KAHRP in P. falciparum, respectively.
VESA proteins have been involved in cytoadhesion and have undergone antigenic variation encoded
by the ves multigene family. The VESA proteins are responsible for the adherence to unknown host
receptors and, like the Plasmodium PfEMP proteins, are deemed as B. bovis virulence factors (Figure 4).
Yet, although no significant sequence similarities exist between the PfEMP and VESA proteins, they both
seem to share similar features and functional roles. The intracellular C-terminal portion of VESA could
also be interacting with the parasite proteins involved in the formation of ridges and cytoskeleton host
proteins (Figure 4) as is the case with PfEMP and KAHRP in Plasmodium [62,63]. Similar to KAHRP,
the SBP2 proteins contain an N-terminal signal peptide, PEXEL motif, form tandem repeat regions
(just in SBP2) and protein binding domains.
Based on recent experimental evidence and similar findings in related parasites, we propose a
model of modulation of virulence based on the interplay of parasite proteins that are secreted into
the erythrocyte cytoplasm and on the surface of the infected erythrocyte. We based our model on the
known VESA proteins, the only so far well-characterized virulence factor in B. bovis and the SBP2t11
protein, the first attenuation factor described, but no doubt, other still uncharacterized proteins may
play important roles in this process (Figure 4). This model suggests that SBP2 truncated proteins,
such as SBP2t11, might be involved in protein-protein interactions in a mode that inhibits or regulates
ridge formation in B. bovis infected erythrocytes. Thus, overexpression of the truncated SBP2t11
may tip the balance on the attenuation side by decreasing the number of ridges in infected cells,
concomitant with reduced cytoadhesion and parasite virulence (Figure 4). This model is supported
by the structural features shared among sbp2t11 and similar exported PEXEL processed Plasmodium
proteins involved in knob formation, which is the confirmed observations that SBP2 truncated protein,
especially SBP2t11, is over-expressed in attenuated phenotypes, and the findings of the current
study demonstrate that infected erythrocytes overexpressing SBP2t11 have a reduced cytoadhesion
phenotype [53]. In summary, current data are consistent with the hypothesis that over-expression of
SBP2t11 interposes with the protein network described for the virulent phenotype, reducing ridge
formation, and cytoadherence in attenuated parasite, suggesting SBP2t11 as a possible modulator of
virulence in B. bovis (Figure 4). More research to identify novel attenuation and virulence factors in
B. bovis is therefore needed to clarify this process further, filling a research gap that can be exploited for
generating new vaccines and methods for the control of bovine babesiosis.
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